Skip to main content
Equibles
HBIO logo

HBIO · Harvard Bioscience Inc · Webcasts, Transcripts & Audio

Track HBIO — free

Use HBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.34 +0.21 (+2.58%) At close · Oct 2
Rebalance outlook locked
Market Cap
$36.24M
Shares
4.55M
Volume · Oct 2 15.47K Avg daily vol (3M) 17.96K

Harvard Bioscience Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Harvard Bioscience Inc (HBIO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼9.2% $26.92M −$3.40M '22 Q3 22-11-08 ▼14% $28.43M −$1.67M '22 Q4 23-03-09 ▲4.2% $29.98M $622,000 '23 Q1 23-04-25 ▼1.5% $28.76M −$980,000 '23 Q2 23-08-08 ▼5.8% $25.36M −$1.24M '23 Q3 23-11-07 ▼1% $28.15M −$1.82M '23 Q4 24-03-07 ▼18.2% $24.51M −$4.69M '24 Q1 24-05-07 ▼19.7% $23.10M −$2.93M '24 Q2 24-08-08 ▼13.4% $21.97M −$4.80M '24 Q3 24-11-07 ▼12.8% $24.56M $18,000 '24 Q4 25-03-19 ▼11.2% $21.77M −$50.34M '25 Q1 25-05-12 ▼11.5% $20.45M −$2.28M '25 Q2 25-08-11 ▼6.3% $20.59M −$1.23M '25 Q3 25-11-06 ▼3.3% $23.73M −$2.85M '25 Q4 26-03-12 ▼4.7% $20.75M −$3.42M '26 Q1 26-05-12 LATEST ▲11.1% $22.73M −$2.91M '26 Q2 26-08-11
Earnings call
FY26 · Q2
2026-08-11
Harvard Bioscience Inc (HBIO) Q2 2026 Earnings Call
Revenue
$22.73M
▲ 11.1% YoY
Diluted EPS
$-0.64
Gross margin
55.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Transcript
Positive tone NPI/translational science products (Mesh MEA, BTX, Soho) Adjusted EBITDA and profitability Academic and NIH budget environment
Revenue
$20.75M
▼ 4.7% YoY
Diluted EPS
$-0.77
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Transcript
Positive tone Q4 2025 Financial Results 2026 Guidance and Outlook Financial Restructuring and Refinancing
Revenue
$23.73M*
▼ 3.3% YoY
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Transcript
Positive tone Gross margin and adjusted EBITDA expansion NIH funding and government shutdown risk Order growth and backlog momentum
Revenue
$20.59M
▼ 6.3% YoY
Diluted EPS
$-0.30
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Transcript
Balanced tone Revenue performance and guidance NIH and academic budget uncertainty Tariffs and China/APAC
Revenue
$20.45M
▼ 11.5% YoY
Diluted EPS
$-0.52
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Transcript
Cautious tone New product launches Revenue softness Cost actions and margin pressure
Revenue
$21.77M
▼ 11.2% YoY
Diluted EPS
$-11.42
Gross margin
56.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-19
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Transcript
Balanced tone Quarterly and annual revenue trends MEA and MeshMEA product growth Bioproduction and gene-editing opportunities
Revenue
$24.56M*
▼ 12.8% YoY
Gross margin
57.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Transcript
Balanced tone Regional revenue performance CRO and biopharma spending environment New product commercialization
Revenue
$21.97M
▼ 13.4% YoY
Diluted EPS
$-1.10
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Transcript
Cautious tone Preclinical / CRO and biopharma capital spending New product initiatives and growth drivers China and Asia Pacific demand
Revenue
$23.10M
▼ 19.7% YoY
Diluted EPS
$-0.70
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings Call Transcript
Cautious tone New product launches and high-growth opportunities Base business and telemetry leadership Revenue softness and regional headwinds
Revenue
$24.51M
▼ 18.2% YoY
Diluted EPS
$-1.10
▼ 1200% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
Harvard Bioscience Inc (HBIO) Q4 2023 Earnings Call Transcript
Positive tone New product commercialization Bioproduction and electroporation China weakness
Revenue
$28.15M*
▼ 1% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Harvard Bioscience Inc (HBIO) Q3 2023 Earnings Call Transcript
Revenue
$25.36M
▼ 5.8% YoY
Diluted EPS
$-0.30
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Harvard Bioscience Inc (HBIO) Q2 2023 Earnings Call Transcript
Revenue
$28.76M
▼ 1.5% YoY
Diluted EPS
$-0.20
▼ 133.3% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Harvard Bioscience Inc (HBIO) Q1 2023 Earnings Call Transcript
Revenue
$29.98M
▲ 4.2% YoY
Diluted EPS
$0.10
Gross margin
61.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
Harvard Bioscience Inc (HBIO) Q4 2022 Earnings Call Transcript
Revenue
$28.43M*
▼ 14% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Harvard Bioscience Inc (HBIO) Q3 2022 Earnings Call Transcript
Revenue
$26.92M
▼ 9.2% YoY
Diluted EPS
$-0.80
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Harvard Bioscience Inc (HBIO) Q2 2022 Earnings Call Transcript
Revenue
$29.21M
▲ 0% YoY
Diluted EPS
$0.60
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Harvard Bioscience Inc (HBIO) Q1 2022 Earnings Call Transcript
Revenue
$28.78M
▲ 6.6% YoY
Diluted EPS
$-1.70
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Harvard Bioscience Inc (HBIO) Q4 2021 Earnings Call Transcript
Revenue
$33.05M*
▲ 6.7% YoY
Gross margin
59.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Harvard Bioscience Inc (HBIO) Q3 2021 Earnings Call Transcript
Revenue
$29.66M
▲ 23.4% YoY
Gross margin
55.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Harvard Bioscience Inc (HBIO) Q2 2021 Earnings Call Transcript
Revenue
$29.20M
▲ 25.3% YoY
Diluted EPS
$-0.10
Gross margin
56.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Harvard Bioscience Inc (HBIO) Q1 2021 Earnings Call Transcript
Revenue
$26.99M
▲ 13.5% YoY
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
Harvard Bioscience Inc (HBIO) Q4 2020 Earnings Call Transcript
Revenue
$30.98M*
▲ 0% YoY
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Harvard Bioscience Inc (HBIO) Q3 2020 Earnings Call Transcript
Revenue
$24.04M
▼ 12.3% YoY
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Harvard Bioscience Inc (HBIO) Q2 2020 Earnings Call Transcript
Revenue
$23.31M
▼ 21.2% YoY
Diluted EPS
$-0.40
Gross margin
59.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Harvard Bioscience Inc (HBIO) Q1 2020 Earnings Call Transcript
Revenue
$23.77M
▼ 15.7% YoY
Diluted EPS
$-1.20
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
Harvard Bioscience Inc (HBIO) Q4 2019 Earnings Call
Revenue
$30.97M
▼ 8.5% YoY
Diluted EPS
$0.20
▼ 75% YoY
Gross margin
55.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1123494 CUSIP 416906204 13F (30d) 1 filings 1 filers Visit website Investor relations